Endocrine Research Center, Vali-asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mol Biol Rep. 2012 Apr;39(4):3791-7. doi: 10.1007/s11033-011-1156-9. Epub 2011 Jul 10.
The relation of Two single nucleotide polymorphisms (SNPs) at the adiponectin locus (+45T/G and +276G/T) with coronary artery disease (CAD) is controversial. The aim of the present study was to evaluate the genetic influence of the adiponectin gene polymorphisms in the development of CAD among patients with Type 2 diabetes (T2D). The adiponectin genotypes were detected by polymerase chain reaction and restriction analysis (PCR-RFLP) in our patients. Two adiponectin gene (ADIPOQ) SNPs (i.e. SNPs +45T>G and +276G>T) were genotyped in 114 Type 2 diabetic subjects with CAD, and 127 Type 2 diabetic patients without CAD. Demographic and anthropometric data along with plasma biochemistry including lipids, glycemic indices, and adiponectin were collected. There was a significant difference in the distribution of genotypes of +45T/G and +276G/T between CAD and non-CAD individuals (P < 0.05). Based on our results SNP+276G>T is associated with decreased risk of CAD after adjustment for potential confounding factors [adjusted OR = 0.39 (95%CI: 0.22-0.68); P = 0.001]. Similar findings were not observed for the +45T>G SNP. Two haplotypes 45T-276T and 45G-276T were associated with a decreased risk of CAD [adjusted OR = 0.47 (95% CI: 0.32-0.94); P = 0.03 and adjusted OR = 0.33 (95% CI: 0.13-0.83); P = 0.02 respectively]. No significant difference was observed between HOMA-IR, BMI, waist circumference, history of hypertension, HbA1C, and lipid concentrations regarding the two SNPs. In conclusion, these findings suggest that T allele of +276G>T SNP is significantly associated with decreased risk of CAD in T2D Patients. Also Haplotype analysis showed that two haplotypes 45T-276T and 45G-276T were associated with a decreased risk of CAD.
在脂联素基因座(+45T/G 和+276G/T)的两个单核苷酸多态性(SNP)与冠心病(CAD)的关系仍存在争议。本研究旨在评估脂联素基因多态性在 2 型糖尿病(T2D)患者 CAD 发展中的遗传影响。我们的患者通过聚合酶链反应和限制性分析(PCR-RFLP)检测脂联素基因型。在 114 例患有 CAD 的 2 型糖尿病患者和 127 例无 CAD 的 2 型糖尿病患者中,对两种脂联素基因(ADIPOQ)SNP(即 SNPs +45T>G 和+276G>T)进行了基因分型。收集了人口统计学和人体测量数据以及包括脂质、血糖指数和脂联素在内的血浆生化指标。CAD 和非 CAD 个体之间+45T/G 和+276G/T 基因型的分布存在显著差异(P<0.05)。基于我们的结果,SNP+276G>T 在调整潜在混杂因素后与 CAD 风险降低相关[调整后的 OR=0.39(95%CI:0.22-0.68);P=0.001]。对于+45T>G SNP,未观察到类似的发现。两种单倍型 45T-276T 和 45G-276T 与 CAD 风险降低相关[调整后的 OR=0.47(95%CI:0.32-0.94);P=0.03 和调整后的 OR=0.33(95%CI:0.13-0.83);P=0.02]。关于这两个 SNP,HOMA-IR、BMI、腰围、高血压病史、HbA1C 和血脂浓度之间没有显著差异。总之,这些发现表明,+276G>T SNP 的 T 等位基因与 T2D 患者 CAD 风险降低显著相关。此外,单体型分析表明,两种单体型 45T-276T 和 45G-276T 与 CAD 风险降低相关。